Key result
Introduction of high-sensitivity cardiac troponin I assays reduced median time spent in the ED and increased coronary angiography rates, without changing admission rates.
Why the study?
Does the introduction of high-sensitivity cardiac troponin I assays improve ED triage times and clinical outcomes in patients presenting with suspected ACS?
Observational (n=12,360)
No
Does the introduction of high-sensitivity cardiac troponin I assays improve ED triage times and clinical outcomes in patients presenting with suspected ACS?
The introduction of high-sensitivity troponin I assays in the ED reduced patient wait times and increased angiography rates without altering overall admission or revascularization rates.
Answers are grounded in this paper and cite their sources.
May shorten ED stays in suspected ACS; observational data leaves net benefit open.
OBJECTIVE: To determine whether introduction of high-sensitivity cardiac troponin I (hscTn-I) assays affected management of patients presenting with suspected acute coronary syndrome (ACS) to the emergency department (ED) of a tertiary referral hospital. DESIGN, PATIENTS AND SETTING: A retrospective analysis of all patients presenting to the Geelong Hospital ED with suspected ACS from 23 April 2010 to 22 April 2013 -2 years before and 1 year after the changeover to hscTn-I assays on 23 April 2012. MAIN OUTCOME MEASURES: Hospital admission rates, time spent in the ED, rates of coronary angiography, rates of percutaneous coronary intervention (PCI) and coronary artery bypass graft surgery (CABGS), rates of discharge with a diagnosis of ACS, and rates of inhospital mortality. RESULTS: 12 360 consecutive patients presented with suspected ACS during the study period; 1897 were admitted to Geelong Hospital in the 2 years before and 944 in the 1 year after the changeover to hscTn-I assays. Comparing the two patient groups, there was no statistically significant difference in all-hospital admission rates (95% CI for the difference, - 3.1% to 0.3%; P = 0.10) or proportion of patients subsequently discharged with a diagnosis of ACS (95% CI for the difference, - 2.3% to 5.4%; P = 0.43). After the changeover, the median time patients spent in the ED was 11.5% shorter (3.85 h v 4.35 h; 95% CI for the difference, - 0.59 to - 0.43; P < 0.001) and the proportion of admitted patients undergoing coronary angiography was higher (53.4% v 45.2%; 95% CI for the difference, 4.3 to 12.0 percentage points; P < 0.001), but there was no statistically significant rise in the proportion of patients who had invasive treatment (PCI and/or CABGS) (95% CI for the difference, - 0.4% to 6.3%; P = 0.08). Inhospital mortality rates from ACS did not change significantly (95% CI for the difference, - 1.5% to 0.8%; P = 0.43). CONCLUSION: The introduction of hscTn-I assays appeared to be associated with more rapid diagnosis, resulting in less time spent in the ED, without a change in hospital admission rates. A higher proportion of patients had coronary angiographies after the changeover, but there was no significant change in rates of invasive treatment or inhospital mortality.
No takes yet. Share an insight, caveat, or question.
Yip et al. (2014) conducted an observational in suspected acute coronary syndrome (ACS) (n=12,360). high-sensitivity cardiac troponin I (hscTn-I) assays vs. standard troponin assays (pre-changeover) was evaluated on Time spent in the ED (hours) (Difference, 95% CI -0.59 to -0.43, p=<0.001). Introduction of high-sensitivity cardiac troponin I assays reduced median time spent in the ED and increased coronary angiography rates, without changing admission rates.
Synapse has enriched 10 related papers. Consider them for comparative context: